Christina A. von Roemeling
University of Florida(US)Florida College(US)
Publications by Year
Research Areas
Cancer, Lipids, and Metabolism, Epigenetics and DNA Methylation, Histone Deacetylase Inhibitors Research, Biomarkers in Disease Mechanisms, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity(2020)238 cited
- → Correction: Corrigendum: Surface modification of nanoparticles enables selective evasion of phagocytic clearance by distinct macrophage phenotypes(2016)48 cited
- → Abstract LB-111: Neuronal Pentraxin 2: a novel tumor-specific molecular target that mediates clear cell renal cell carcinoma malignancy(2014)2 cited
- → Abstract LB-210: Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma.(2013)1 cited
- → Abstract P243: The IRAK4 inhibitor CA-4948 demonstrates antitumor activity in a preclinical model of CNS lymphoma(2021)1 cited
- → Abstract LB-95: Estrogen receptor mRNA-directed therapy for triple-negative breast cancer(2014)1 cited
- → Supplementary Figure 1 from Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma(2023)
- → Supplementary Data from Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma(2023)
- → Supplementary Figure 4 from Stearoyl-CoA Desaturase 1 Is a Novel Molecular Therapeutic Target for Clear Cell Renal Cell Carcinoma(2023)
- → Supplementary Figure 1 from Reexpression of Tumor Suppressor, sFRP1, Leads to Antitumor Synergy of Combined HDAC and Methyltransferase Inhibitors in Chemoresistant Cancers(2023)